Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL
Conditions: Hormone-receptor-positive Breast Cancer|HER2-low Breast Cancer|HER2-negative Breast Cancer
Interventions: OTHER: No drug
Sponsor: Daiichi Sankyo